Advertisement

Supply Chain

Since establishing its own group purchasing organization in 2018, Phoenix-based Banner Health has aimed to drive cost savings and improve supply chain efficiencies across its network. 

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. 

Boston Scientific has recalled its Accolade pacemaker devices due to a manufacturing issue that could cause the devices to enter safety mode, requiring replacement. 

Advertisement

Abiomed, also now known as Johnson & Johnson MedTech, issued a recall for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps due to safety concerns. 

Baxter's North Cove manufacturing facility in Marion, N.C., has returned to pre-hurricane production levels following extensive flooding from Hurricane Helene, which halted operations and triggered a nationwide IV-fluid shortage. 

Advertisement